MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10067-021-05994-z

Медицинская библиотека · Clinical rheumatology · 2021

Gout during the SARS-CoV-2 pandemic: increased flares, urate levels and functional improvement.

García-Maturano Juan Salvador, Torres-Ordaz David Eduardo, Mosqueda-Gutiérrez Miguel, Gómez-Ruiz Citlallyc, Vázquez-Mellado Aarón, Tafoya-Amado Alicia, Peláez-Ballestas Ingris, Burgos-Vargas Rubén, Vázquez-Mellado Janitzia

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Gout is the most common inflammatory arthritis, but was not considered in most COVID-19 and rheumatic diseases reports. Our aim was to describe changes in clinical data, treatment, function and quality of life for gout patients during COVID-19 pandemic.

METHODS

Prospective, descriptive and analytical study of 101 consecutive gout (ACR/EULAR 2015) patients from our clinic evaluated during pandemic by phone call (n=52) or phone call + face-to-face (n=68) that accepted to participate. Variables are demographics, clinical and treatment data, HAQ, EQ5D questionnaires and COVID-19-related data. Patients were divided in two groups: flare (n=36) or intercritical gout (n=65) also; available pre-pandemic data was obtained from 71 patients. Statistical analyses are X2, paired t-test and Wilcoxon test.

RESULTS

Included gout patients were males (95.8%), mean (SD) age 54.7 (10.7) years and disease duration 16.4 (9.8) years; 90% received allopurinol, 50% colchicine as prophylaxis and 25% suspended ≥ 1 medication. Comparison of pre-pandemic vs pandemic data showed > flares (4.4% vs 36%, p=0.01), more flares in the last 6 months: 0.31 (0.75) vs 1.71 (3.1), (p=0.004 and > urate levels: 5.6 (1.7)vs 6.7 (2.2) mg/dL, p=0.016. Unexpectedly, function and quality-of-life scores improved: HAQ score 0.65 (2.16) vs 0.12 (0.17), p= 0.001. Seven patients were COVID-19-confirmed cases; they had significantly more flares, higher urate levels and lower allopurinol doses and two died.

CONCLUSIONS

In gout patients, flares were 9 times more frequent during pandemic also, they had increased urate levels but led to an unexpected improvement in HAQ and functionality scores. Resilience and lifestyle changes in gout during COVID-19 pandemic require further studies. Key Points • COVID-19 pandemic is associated with 4 times more flares in gout patients. • Increased flares were also seen in previously well-controlled gout patients. • Increased serum urate levels were also found in gout patients during pandemic. • In our gout clinic, 8/101 patients were diagnosed as COVID-19+, and two of them died.

Для цитирования: García-Maturano Juan Salvador, Torres-Ordaz David Eduardo, Mosqueda-Gutiérrez Miguel, Gómez-Ruiz Citlallyc, Vázquez-Mellado Aarón, Tafoya-Amado Alicia, Peláez-Ballestas Ingris, Burgos-Vargas Rubén, Vázquez-Mellado Janitzia. Gout during the SARS-CoV-2 pandemic: increased flares, urate levels and functional improvement.. Clinical rheumatology. 2021. DOI: 10.1007/s10067-021-05994-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.